Skip to main content
Signal8

ALLURION TECHNOLOGIES, INC. (ALUR)

Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Allurion Technologies Inc. logo

Allurion Technologies Inc.

OTC:ALUROTC (delisted from NYSE, Form 25 effective Oct 23, 2026)Healthcare
+5.00%$0.0021
Mkt Cap$1K
EV-
Float575K
O/S608K
VOL418 sh
$ Vol$1
RVOL0.60×
Inst Own7.4%
SI0.2%
Net Cash/Sh-
Dilution
Allurion Technologies Inc. logoOTC:ALUR$0.0021+5.00%

ALLURION TECHNOLOGIES, INC. (ALUR) dilution facts from SEC filings

Snapshot as of Mar 31, 2026, built from 39 SEC filings.

Shelf registration
S-3 filed Jan 9, 2026, effective Jan 16, 2026
Source: 424B3 filed Jan 20, 2026
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
17 warrant series recorded as outstanding
Most recent offering
Offering, closed Feb 26, 2026
Source: 10-Q filed May 15, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro